2. Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practic...
在2023年ACC/AHA/ACCP/HRS心房颤动诊断与管理指南中,最引人注目的变化之一是对心房颤动(AF)分类方法的更新。这一改革性的步骤是根据心房颤动发展的各个阶段来进行分类,从而为临床医生提供了一个更清晰、更全面的管理框架。相比于以往仅...
1.Joglar JA, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 Jan 2;149(1):e1-e156. 2. Romiti GF, et...
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation 3 3 3Journal of the American College of Cardiology
The Update Points of 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation 作者: 胡晓芹1; 2 胡淼阳 3 陈明龙1?/html> ?1.南京医科大学第一附属医院心内科,江苏 南京 210029;2.徐州医科大学附属医院心内科,江苏 徐州 221000;3.空军军医大学第一附属医院西京医院心内科...
ACC/AHA/ESC 2006 of the guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (Writing Committee to Revise ...
(%)aI-AI-BI-CII-AII-BII-CIII-AIII-BIII-CDisease guidelinesAtrial fibrillation (n = 111)20068 (7.2)12 (10.8)21 (18.9)3 (2.7)18 (16.2)34 (30.6)2 (1.8)3 (2.7)10 (9.0)Heart failure (n = 129)200520 (15.5)13 (10.1)33 (25.6)9 (7.0)11 (8.5)24 (18.6)5 (3.9)1 (0.8)13 ...
AF atrial fibrillation ARB angiotensin receptor blocker ARNI angiotensin receptor-neprilysin inhibitor BNP B-type natriuretic peptide CAD coronary artery disease COR Class of Recommendation CRT cardiac resynchronization therapy ESC European Society of Cardiology ESCG European Society of Cardiology guidelines GDMT...
2023;6(9):e2335722. doi:10.1001/jamanetworkopen.2023.35722 Introduction The CHA2DS2-VASc score identifies patients with atrial fibrillation (AF) who are likely to derive net clinical benefit from oral anticoagulation (OAC).1 One component of CHA2DS2-VASc is hypertension, defined by contemporary ...
from the earlier heart failure guidelines have been updated when supported by published data. Value statements are analyses. MESSAGES medical therapy (GDMT) for heart ith reduced ejection fraction (HFrEF) 4 medication classes that include se cotransporter-2 inhibitors (SGLT2i). ...